Regeneron ends development of RSV antibody
Regeneron dumps suptavumab after phase 3 trial failure.
X
Regeneron ends development of RSV antibody
https://pharmaphorum.com/news/regeneron-ends-development-of-rsv-antibody/
Regeneron dumps suptavumab after phase 3 trial failure.